| Mrs Rachel Lynne West, LPN | |
|
15126 Dunwood Trl, Apple Valley, MN 55124-5854 | |
| (952) 457-5064 | |
| Not Available |
| Full Name | Mrs Rachel Lynne West |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 15126 Dunwood Trl, Apple Valley, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164766275 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | 072468-7 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Rachel Lynne West, LPN 15126 Dunwood Trl, Apple Valley, MN 55124-5854 Ph: (952) 457-5064 | Mrs Rachel Lynne West, LPN 15126 Dunwood Trl, Apple Valley, MN 55124-5854 Ph: (952) 457-5064 |
News Archive
Mice transplanted with cells grown from a patient suffering from Huntington's disease (HD) develop the clinical features and brain pathology of that patient, suggests a study published in the latest issue of Acta Neuropathologica by CHA University in Korea, in collaboration with researchers at Université Laval in Québec City, Canada.
National Jewish Health has received a grant for $950,308 from GlaxoSmithKline to improve care of asthma patients in Colorado's San Luis Valley with educational materials for patients and hands-on training for primary health care teams.
ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique, tightly controlled lac promoter.
Imagine having feelings of distress and negativity at some point as you are going about your day. Then imagine feeling that way every day, for almost 21 days. Lesbian, gay, bisexual, transgender and queer youth don't have to imagine having negative feelings at some point throughout the day for an extended period of days.
ADVANCELL, an emerging biopharmaceutical company, today announced positive results from a clinical study conducted with Acadra (Acadesine) in Chronic Lymphocytic Leukemia patients resistant to current therapies. The company also announced promising non-clinical results in Multiple Myeloma (MM), Mantle Cell Lymphoma (MCL) and other lymphoproliferative disorders. Synergism of Acadra in combination with current treatment in these indications has been demonstrated.
› Verified 5 days ago